sb 203580 has been researched along with Chloasma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JY; Han, BS; Kang, M; Lee, J; Lee, S; Lee, SE; Nho, YH; Oh, SW; Park, SH; Yoo, JA | 1 |
1 other study(ies) available for sb 203580 and Chloasma
Article | Year |
---|---|
Anti-melanogenic effects of resorcinol are mediated by suppression of cAMP signaling and activation of p38 MAPK signaling.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Drug Interactions; Enzyme Activation; Gene Expression; Humans; Imidazoles; Indoles; Intramolecular Oxidoreductases; MAP Kinase Signaling System; Melanins; Melanocytes; Melanosis; Membrane Glycoproteins; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Oxidoreductases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Real-Time Polymerase Chain Reaction; Resorcinols | 2018 |